These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27530841)

  • 1. First reported case of an OXA-48-producing isolate from a Colombian patient.
    Vanegas JM; Ospina WP; Felipe Higuita-Gutiérrez L; Natalia Jiménez J
    J Glob Antimicrob Resist; 2016 Sep; 6():67-68. PubMed ID: 27530841
    [No Abstract]   [Full Text] [Related]  

  • 2. First isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal.
    Conceição T; Brízio A; Duarte A; Barros R
    Antimicrob Agents Chemother; 2005 Jan; 49(1):476. PubMed ID: 15616343
    [No Abstract]   [Full Text] [Related]  

  • 3. First description of KPC-2-producing Klebsiella oxytoca in Brazil.
    Almeida AC; Cavalcanti FL; Martins WM; Vilela MA; Gales AC; Morais Junior MA; Morais MM
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4077-8. PubMed ID: 23752512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a blaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary.
    Kristóf K; Tóth A; Damjanova I; Jánvári L; Konkoly-Thege M; Kocsis B; Koncan R; Cornaglia G; Szego E; Nagy K; Szabó D
    J Antimicrob Chemother; 2010 Jun; 65(6):1303-5. PubMed ID: 20410063
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient in a cardiac rehabilitation unit.
    Caltagirone M; Bitar I; Piazza A; Spalla M; Nucleo E; Navarra A; Migliavacca R
    New Microbiol; 2015 Jul; 38(3):387-92. PubMed ID: 26147151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
    Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
    Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital.
    Hays C; Benouda A; Poirel L; Elouennass M; Nordmann P
    Int J Antimicrob Agents; 2012 Jun; 39(6):545-7. PubMed ID: 22521525
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome sequence of Klebsiella oxytoca 11492-1, a nosocomial isolate possessing a FOX-5 AmpC β-lactamase.
    Hazen TH; Robinson GL; Harris AD; Rasko DA; Johnson JK
    J Bacteriol; 2012 Jun; 194(11):3028-9. PubMed ID: 22582383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity.
    Nijhuis RH; Oueslati S; Zhou K; Bosboom RW; Rossen JW; Naas T
    J Antimicrob Chemother; 2015 May; 70(5):1429-33. PubMed ID: 25630648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
    Fujita A; Kimura K; Yokoyama S; Jin W; Wachino J; Yamada K; Suematsu H; Yamagishi Y; Mikamo H; Arakawa Y
    PLoS One; 2015; 10(11):e0142366. PubMed ID: 26539828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic abscess caused by New Delhi metallo-β-lactamase-1-producing Klebsiella oxytoca in Taiwan in a patient who underwent renal transplantation in China.
    Lai CC; Lin TL; Tseng SP; Huang YT; Wang JT; Chang SC; Teng LJ; Wang JT; Hsueh PR
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):474-5. PubMed ID: 22083082
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceftazidime-resistant Klebsiella oxytoca producing an OXY-2-type variant from Switzerland.
    Rodríguez-Martínez JM; Poirel L; Nordmann P; Fankhauser C; Francois P; Schrenzel J
    Int J Antimicrob Agents; 2008 Sep; 32(3):278-9. PubMed ID: 18602252
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.
    Chen LR; Zhou HW; Cai JC; Zhang R; Chen GX
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):163-7. PubMed ID: 19748427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of multidrug-resistant Klebsiella oxytoca carrying blaIMP-8, associated with OXY hyperproduction, in the intensive care unit of a community hospital in Spain.
    Conejo MC; Domínguez MC; López-Cerero L; Serrano L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2010 May; 65(5):1071-3. PubMed ID: 20215129
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of metallo-β-lactamase genes in clinically isolated Klebsiella pneumoniae and Klebsiella oxytoca.
    Tateno H; Yasuhara T; Sugano E; Tahara S; Ugajin K; Fukuchi K
    Rinsho Byori; 2014 Dec; 62(12):1191-6. PubMed ID: 25823233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 beta-lactamase.
    Potz NA; Colman M; Warner M; Reynolds R; Livermore DM
    J Antimicrob Chemother; 2004 Mar; 53(3):545-7. PubMed ID: 14963067
    [No Abstract]   [Full Text] [Related]  

  • 17. [ESBL-positive and ESBL-negative Klebsiella pneumoniae and Klebsiella oxytoca strains--occurrence in clinical specimens and susceptibility to selected antibiotics].
    Sekowska A; Wróblewska J; Gospodarek E
    Med Dosw Mikrobiol; 2008; 60(1):39-44. PubMed ID: 18634342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTX-M-producing Klebsiella spp. in a Brazilian hospital: what has changed in 6 years?
    Clímaco EC; Minarini LA; da Costa Darini AL
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):186-9. PubMed ID: 20846594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of resistance of a highly carbapenem-resistant Klebsiella oxytoca isolate and comparison of susceptibility to five carbapenems.
    Sho T; Muratani T; Mizokami Y; Hamasuna R; Fujimoto N; Matsumoto T
    Int J Antimicrob Agents; 2012 Mar; 39(3):268-9. PubMed ID: 22226923
    [No Abstract]   [Full Text] [Related]  

  • 20. Complete nucleotide sequence of the IncN plasmid pKOX105 encoding VIM-1, QnrS1 and SHV-12 proteins in Enterobacteriaceae from Bolzano, Italy compared with IncN plasmids encoding KPC enzymes in the USA.
    Carattoli A; Aschbacher R; March A; Larcher C; Livermore DM; Woodford N
    J Antimicrob Chemother; 2010 Oct; 65(10):2070-5. PubMed ID: 20656680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.